Zacks Investment ResearchTue, 07 Jul 2026 17:11:06 GMTWhy Biogen (BIIB) is Poised to Beat Earnings Estimates AgainBIIB-1.32%
The Motley FoolSat, 04 Jul 2026 08:02:00 GMTBiogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.BIIB-1.32%
Zacks Investment ResearchMon, 29 Jun 2026 13:11:09 GMTBiogen (BIIB) Moves 7.0% Higher: Will This Strength Last?BIIB-1.32%
Zacks Investment ResearchFri, 26 Jun 2026 13:21:05 GMTCan Biogen's New Drugs Revive Growth Amid Legacy Sales Slump?BIIB-1.32%
Zacks Investment ResearchThu, 18 Jun 2026 14:55:24 GMTBiogen to Strengthen Immunology Pipeline With $1B RayThera BuyoutBIIB-1.32%
BenzingaMon, 08 Jun 2026 13:58:05 GMTThis Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For MondayBIIB-1.32%
Zacks Investment ResearchFri, 29 May 2026 16:32:08 GMTWhy Is Biogen (BIIB) Up 3.8% Since Last Earnings Report?BIIB-1.32%
Zacks Investment ResearchFri, 29 May 2026 14:55:34 GMTShould You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?BIIB-1.32%
Seeking AlphaTue, 26 May 2026 12:11:55 GMTLeqembi Isn't Enough To Save Biogen Momentum (Rating Downgrade)BIIB-1.32%
Zacks Investment ResearchFri, 22 May 2026 17:15:26 GMTDenali Stock Dips as Biogen-Partnered Parkinson's Disease Study FailsBIIB-1.32%
MarketBeatFri, 22 May 2026 11:50:33 GMTBiogen Stock Slides After Trial Miss, But Analysts Stay BullishBIIB-1.32%
Seeking AlphaFri, 15 May 2026 15:10:59 GMTBiogen: Apellis Acquisition, Alzheimer's Fail Sums Up Mixed Investment OpportunityBIIB-1.32%
MarketBeatThu, 14 May 2026 23:10:47 GMTBiogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology PushBIIB-1.32%
CNBCThu, 14 May 2026 16:10:48 GMTBiogen advances Alzheimer's drug to late-stage trial despite disappointing dataBIIB-1.32%
BarronsThu, 14 May 2026 13:07:00 GMTBiogen's Alzheimer's Drug Fell Short of Targets. Why the Stock Is Rising Anyway.BIIB-1.32%
Seeking AlphaWed, 13 May 2026 21:10:50 GMTBiogen Inc. (BIIB) Presents at Bank of America Global Healthcare Conference 2026 TranscriptBIIB-1.32%
BenzingaThu, 30 Apr 2026 15:57:06 GMTBiogen Analysts Boost Their Forecasts Following Upbeat Q1 EarningsBIIB-1.32%
Seeking AlphaWed, 29 Apr 2026 18:21:41 GMTBiogen Inc. (BIIB) Q1 2026 Earnings Call TranscriptBIIB-1.32%
Zacks Investment ResearchWed, 29 Apr 2026 12:10:48 GMTBiogen Inc. (BIIB) Tops Q1 Earnings and Revenue EstimatesBIIB-1.32%
